Preview: Immunogen's Earnings
Portfolio Pulse from Benzinga Insights
Immunogen (NASDAQ:IMGN) is set to release its latest quarterly earnings report on Monday, 2023-07-31. Analysts estimate an earnings per share (EPS) of $-0.14. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $18.46 and has seen a 327.7% increase over the last 52-week period.
July 28, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Immunogen is expected to report an EPS of $-0.14 in its upcoming earnings. The stock has seen a significant increase over the past year, and the earnings report could influence its price.
The upcoming earnings report is a significant event for Immunogen. While the company's past earnings have had a mixed impact on the stock price, the overall trend for the stock has been positive over the past year. The estimated EPS of $-0.14 will be a key figure to watch, as beating or missing this estimate could influence the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100